Methodology Study To Examine 6-Week Food Intake With Liraglutide In Obese Subjects

Completed · Phase 1 · Has a placebo group

Conditions studied: Obesity

In brief

This will be a randomized, double blind, placebo controlled, 2 arm, parallel group, methodology study to assess the effect of 6 weeks of liraglutide administration on food intake in obese subjects.

Key facts

Study ID

NCT03041792

Run by

Pfizer

People needed

61

Starts

2017-02-20

Expected to finish

2018-01-16

Last updated by the study team

2019-07-26

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Males and female subjects;
• Body Mass Index 30-40 kg/m2;

You may not qualify if…

• Evidence of history of clinically significant hematological, renal, endocrine, pulmonary, gastrointestinal, cardiovascular, hepatic, psychiatric, neurologic, or allergic disease (including drug allergises, but excluding untreated, asymptomatic, seasonal allergies at time of dosing)

Where it is running

• Translational Research Institute for Metabolism and Diabetes — Orlando, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.